Differentiation of Acute Leukemia Cells Including Cells with MLL-AF4 Rearrangements Induced by Jiyuan Oridonin A

CONCLUSION: Our results suggest that JOA may be considered a promising anti-leukemia compound to develop to surmount the differentiation block in AL patients.PMID:38204268 | DOI:10.2174/0115748928263141231204112640

Source: Recent Patents on Anti-Cancer Drug Discovery - January 11, 2024 Category: Cancer & Oncology Authors: Xueming Li Fenglian Zhang Yu Ke Hongmin Liu Zhenbo Hu Liuya Wei Source Type: research